| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |